# Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds

> **NCT04346667** · PHASE4 · TERMINATED · sponsor: **Government of Punjab, Specialized Healthcare and Medical Education Department** · enrollment: 125 (actual)

## Conditions studied

- SARS-CoV-2
- Coronavirus Infection
- Asymptomatic Condition
- COVID-19

## Interventions

- **DRUG:** Hydroxychloroquine Sulfate Regular dose
- **DRUG:** Hydroxychloroquine Sulfate Loading Dose
- **DRUG:** Chloroquine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04346667
- **Lead sponsor:** Government of Punjab, Specialized Healthcare and Medical Education Department
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-04-14
- **Primary completion:** 2020-08-23
- **Final completion:** 2020-08-30
- **Target enrollment:** 125 (ACTUAL)
- **Why stopped:** Poor accrual.
- **Last updated:** 2021-03-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04346667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04346667, "Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04346667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*